A study released Friday found that kid-size doses of Pfizer’s Covid vaccine are nearly 91 percent effective at preventing symptomatic infections in 5- to 11-year-olds.
Related Articles
-
Regular Covid antibody shots could protect people with weak immune systems
Even as the Covid delta wave ebbs in the U.S., millions of people with compromised immune systems remain trapped...
-
Excess deaths due to pandemic are 3 times higher than official Covid toll, study finds
The number of people worldwide who died because of the pandemic in its first two years may total more...
-
More than 500 people asked to test for tuberculosis after case at Nebraska day care
A Nebraska health department is investigating more than 500 possible exposures to tuberculosis linked to an active case at...
-
Experimental drug for marijuana addiction shows promise, small study finds
As marijuana use in the United States reaches record highs among young adults, there is a growing need to...
-
RFK Jr.-appointed CDC vaccine panel says it will scrutinize the childhood vaccine schedule
A federal vaccine advisory committee plans to review the childhood vaccination schedule and scrutinize vaccines that have been approved...
-
Latino community clinics battled Covid head on. Now they want a shot at more vaccines.
The staff of El Centro de Corazón health clinics knew that Covid-19’s strike would be more vicious in Houston’s...
-
U.K.’s Johnson launches mass testing program as economy reopens
LONDON — British Prime Minister Boris Johnson said on Monday everyone in England will be able to take a...
-
Monkeypox misinformation is spreading faster than the virus, experts say
Misinformation about the monkeypox outbreak is spawning an epidemic of largely unfounded anxiety, experts say. Nearly 1 in 5...
Recent Comments